2004
DOI: 10.1016/j.neulet.2003.12.090
|View full text |Cite
|
Sign up to set email alerts
|

Riluzole restores motor activity in rats with post-traumatic peripheral neuropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 18 publications
1
5
0
Order By: Relevance
“…Regardless of the mechanisms involved, the results suggest that riluzole may have a new role in the promotion of axonal regeneration following peripheral nerve injuries. Consistent with this notion is the recent finding that riluzole can enhance motor activity following peripheral nerve crush injury (Medico et al. , 2004).…”
Section: Discussionsupporting
confidence: 60%
See 2 more Smart Citations
“…Regardless of the mechanisms involved, the results suggest that riluzole may have a new role in the promotion of axonal regeneration following peripheral nerve injuries. Consistent with this notion is the recent finding that riluzole can enhance motor activity following peripheral nerve crush injury (Medico et al. , 2004).…”
Section: Discussionsupporting
confidence: 60%
“…Riluzole has a complex pharmacology; it has anaesthetic, analgesic, anti‐ischaemic and anti‐inflammatory properties in addition to its well‐known anti‐excitotoxic properties (Doble, 1996; Gilgun‐Sherki et al. , 2003; Medico et al. , 2004).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on previous dose-ranging experiments done in our laboratory, phenytoin (administered at 20 mg/kg ip) results in a circulating concentration of ϳ100 M, which is the in vitro dose used. The in vivo dosages are within the therapeutic ranges for humans (33,43,68) and were previously used for animal studies (49,55). Control groups received similar volumes of the drug vehicle, DMSO (8 ml/kg).…”
Section: Methodsmentioning
confidence: 99%
“…Evidence supporting the favorable CNS therapeutic profile of riluzole includes a growing body of work showing that this agent has neuroprotective properties in animal models of brain ischemia [5], spinal cord injury [6, 7], traumatic brain injury [8], Parkinson’s disease [8], post-traumatic peripheral neuropathy [9], and acute noise-induced hearing loss [10]. It has been suggested that inhibition of tyrosine phosphorylation (which is observed in response to brain ischemia) may contribute to riluzole’s neuroprotective properties against excitotoxic injury [11].…”
Section: Mechanism Of Actionmentioning
confidence: 99%